About Reviews Semax: The Editorial Project Behind the Chalkboard

About this Semax editorial project

Reviews Semax is an independent editorial project that publishes summaries of the peer-reviewed research literature on Semax. We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The 'reviews' in the domain name is editorial framing — a reading of the trial record and the user-report record through the published literature, not a product review and not a vendor rating. The chalkboard register is also editorial framing — Semax's evidence base reads like a fifty-year university neurochemistry lecture, with Russian primary sources, Western mechanistic replications, and a small but persistent group of investigators (Myasoedov, Skvortsova, Dergunova, Bashkatova) who have carried the work since the 1980s. The chalkboard lets us show the work — the seven residues, the ACTH lineage, the BDNF cascade, the Pro-Gly-Pro tail — in the register the literature actually deserves.

Everything cited here is documented in the references page. Russian-language entries are identified by PubMed PMID where DOI assignment pre-dates indexing. We do not invent citations and we do not paraphrase claims that are not in the source. When the literature is thin (Western Phase 3 trials), we say so. When it is reproducible (rodent BDNF and NGF upregulation), we say so plainly.

This is one editorial project, written by one editorial team. It does not have a clinic address, a phone number, or prescribing staff. The 'doctor', 'clinic', and 'reviews' framing across the broader portfolio of sites is the editorial position the publisher occupies relative to the literature, not a claim about treatment services.